MMP-9 and TIMP-1 in placenta of hypertensive disorder complicating pregnancy
- Authors:
- Yuyi Zhang
- Peng Li
- Yue Guo
- Xiaowan Liu
- Yubo Zhang
View Affiliations
Affiliations: Department of Gynecology and Obstetrics, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei 441000, P.R. China, Department of General Surgery, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei 441000, P.R. China, Department of Gynecology, People's Hospital of Xinjiang Uygur, Urumqi, Xinjiang Uygur Autonomous Region 830001, P.R. China, Department of Stomatology, Quzhou No. 2 People's Hospital, Jinhua, Zhejiang 321000, P.R. China
- Published online on: May 17, 2019 https://doi.org/10.3892/etm.2019.7591
-
Pages:
637-641
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Expression and characteristics of matrix metalloproteinase-9 (MMP-9) and TIMP metallopeptidase inhibitor-1 (TIMP-1) in the placenta of pregnancy induced hypertension (PIH) were detected in Uygur to analyze its correlation with PIH, and to provide a theoretical basis for clinical work. Ninety cases of placental tissue patients who were hospitalized in the Department of Obstetrics of People's Hospital of Xinjiang Uygur from December 2014 to September 2016 were collected, including 30 cases of severe preeclampsia, 30 cases of mild preeclampsia, and 30 cases of normal group. The distribution of MMP-9 and TIMP-1 in placenta was mainly in the cytoplasm of trophoblast cells, vascular endothelial cells and villous mesenchymal cells. The distribution of MMP-9 positive particles in the placenta tissue of the severe group was significantly reduced. The difference of MMP-9 in the three groups was statistically significant. Severe group was statistically significantly different from normal and mild group. With the aggravation of PIH, positive expression of MMP-9 was gradually decreased. TIMP-1 was expressed in each group, and difference was not statistically significant. Positive expression ratio of MMP-9/TIMP-1 in severe group was lower than that in normal pregnancy and mild group, and positive expression ratio of the two groups became smaller as the condition worsened. Positive expression of MMP-9 in placental tissue of patients with PIH decreased significantly with the severity of PIH. TIMP-1 in placental tissue of PIH patients did not change much in each group, and had no significant correlation with PIH.
View References
1
|
Cerdeira AS and Karumanchi SA: Angiogenic
factors in preeclampsia and related disorders. Cold Spring Harb
Perspect Med. 2:0065852012. View Article : Google Scholar
|
2
|
Vadhera RB and Simon M: Hypertensive
emergencies in pregnancy. Clin Obstet Gynec. 57:797–805. 2014.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Winn VD, Gormley M and Fisher SJ: The
impact of preeclampsia on gene expression at the maternal-fetal
interface. Pregnancy Hypertens. 1:100–108. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kleinrouweler CE, Wiegerinck MM,
Ris-Stalpers C, Bossuyt PM, van der Post JA, von Dadelszen P, Mol
BW and Pajkrt E; EBM CONNECT Collaboration, : Accuracy of
circulating placental growth factor, vascular endothelial growth
factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in
the prediction of pre-eclampsia: A systematic review and
meta-analysis. BJOG. 119:778–787. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Chen J, Yu YH, Wang ZJ, Qin W and Zhang Q:
Relationship between preeclampsia umbilical blood flow and
perinatal outcomes. Nan Fang Yi Ke Da Xue Xue Bao. 29:745–746.
2009.(In Chinese). PubMed/NCBI
|
6
|
Zhu J, Zhong M, Pang Z and Yu Y:
Dysregulated expression of matrix metalloproteinases and their
inhibitors may participate in the pathogenesis of pre-eclampsia and
fetal growth restriction. Early Hum Dev. 90:657–664. 2014.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Shi H, Liu L, Liu LM, Geng J and Chen L:
Inhibition of tumor growth by β-elemene through downregulation of
the expression of uPA, uPAR, MMP-2, and MMP-9 in a murine
intraocular melanoma model. Melanoma Res. 25:15–21. 2015.
View Article : Google Scholar : PubMed/NCBI
|
8
|
McCool WF, Durain D and Davis M: Overview
of latest evidence on uterine fibroids. Nurs Womens Health.
18:314–332. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Jaiswar SP, Gupta A, Sanchan R, Natu SN
and Shaili M: Latic dehydrogenase: A biochemical marker for
preeclampsia-eclampsia. J Obstet Gynaecol India. 61:645–648. 2011.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Maged AM, Aid G, Bassiouny N, Eldin DS,
Dahab S and Ghamry NK: Association of biochemical markers with the
severity of pre-eclampsia. Int J Gynaecol Obstet. 136:138–144.
2017. View Article : Google Scholar : PubMed/NCBI
|
11
|
Sun C, Zhang Q, Hu B and Zhang K:
Investigation of the association between matrix metalloproteinase-9
genetic polymorphisms and development of pre-eclampsia in Chinese
pregnant women. Genet Mol Res. 15:1–6. 2016. View Article : Google Scholar
|
12
|
Zhang YY, Ren HY, Wang YT, Deng J, Liu XW
and Li XY: Expression of MMP-9 and TIMP-1 in placental tissue of
pregnancy-induced hypertension in Uigur women in Xinjiang. Progress
Modern Biomed. 19:3710–3712. 2009.(In Chinese).
|
13
|
Laird SM: Metalloproteinases and tissue
inhibitor ormetalloproteinase-1 (TIMP-1) in endometrial flushings
from pre-and post-menopausal women and from women with endometrial
adenocarcinoma. J Reprod Fertil. 115:225–232. 1999. View Article : Google Scholar : PubMed/NCBI
|